Journal
ONCOGENE
Volume 32, Issue 13, Pages 1626-1637Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/onc.2012.187
Keywords
transformation; oncoprotein; SUMO; phosphorylation
Funding
- Freie und Hansestadt Hamburg
- Bundesministerium fur Gesundheit
- Wilhelm Sander-Stiftung, Munich, Germany
- Canadian Institutes of Health Research
Ask authors/readers for more resources
Since the discovery of post-translational modification (PTM) by the small ubiquitin-related modifiers (SUMOs), a multitude of proteins have been described to be reversibly modified, resulting in the alteration of several cellular pathways. Interestingly, various pathogens gain access to this modification system, although the molecular mechanisms and functional consequences are barely understood. We show here that the adenoviral oncoprotein E1B-55K is a substrate of the SUMO conjugation system, which is directly linked to its C-terminal phosphorylation. This regulative connection is indispensable for modulation of the tumor suppressor p53/chromatin-remodeling factor Daxx by E1B-55K and, consequently, its oncogenic potential in primary mammalian cells. In virus infection, E1B-55K PTMs are necessary for localization to viral transcription/replication sites. Furthermore, we identify the E2 enzyme Ubc9 as an interaction partner of E1B-55K, providing a possible molecular explanation for SUMO-dependent modulation of cellular target proteins. In conclusion, these results for the first time provide evidence how E1B-55K PTMs are regulated and subsequently facilitate exploitation of the host cell SUMOylation machinery. Oncogene (2013) 32, 1626-1637; doi:10.1038/onc.2012.187; published online 21 May 2012
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available